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Abstract 
A series of five (6- mercaptopurine derivatives) have been synthesized as disulfide, Schiff base, Oxadiazole and 
amide products and the activity as anticancer was evaluated against three types of cancer lines. The pilot studies 
indicated that compound 1, 2, 3, 4 and 5 were the active compounds, but only compound (1) reviewed in detail 
.The reaction progress and products purity were checked by thin layer chromatography. The target chemical 
structures of compounds and intermediates were proved by their physicochemical properties as melting points, 
infrared spectroscopy, and elemental microanalysis (CHNS) and proton nuclear magnetic resonance (H1NMR)   
Keywords: cancer, 6 -mercaptopurine, disulfide, penicillamine 
1. Introduction 
Cancer is a complex genetic disease that is caused primarily by environmental factors and genetic factor (1). 
Anticancer or chemotherapy drugs can denature cancer cells by arresting their growth. Though anticancer drugs 
affect dividing cancer cells, normal cells are also affected in the course of the event. (2, 3) 
Today, more than 100 different drugs have been used for chemotherapy, either alone or in combination with 
other treatments. (3,4) Chemotherapy of cancer is associated with various adverse effects bone marrow 
depression, alopecia, drug induced caner, etc. and is often associated with cytotoxicity, gene toxicity to normal 
cells together with the development of resistance , so its important for the search of Newer and safer anticancer 
gents.(5)  
Purine analogs are widely used against various diseases, particularly cancer. The clinical application of 
6- mercaptopurine and Thioguanine in cancer treatment and the development of potent purine based CDK 
inhibitors, such as Purvalanols, Olomoucine, and Roscovitine, together with other findings based on the purine 
scaffold, have largely inspired and directed parallel developments in the chemistry and anti-tumor research of 
related heterocyclic analogs (6), (7),(8) ,(9).  
Azomethine group (C=N) containing compounds typically known as Schiff bases have been synthesized 
by condensation of primary amines with active carbonyl form. Schiff bases from a significant class of 
compounds in medicinal and pharmaceutical chemistry with several biological applications that induce 
anticancer activity (10-21). 
  
2. Experimental work  
2.1 chemical and solvent  
Chemicals used in this work are supplied from HIMEDIA, Fluka and SIGMA companies. All the solvents were 
of annular grade and used without further purification. Cells lines are supplied from Iraqi center for cancer and 
genetic research.  
2.2 instruments  
Melting points were determined by capillary tube method on Banested (UK). The FTIR spectra were recorded on 
FTIR spectrophotometer, Shimadzu (Japan) at the colleges of pharmacy and Science (Baghdad University).The 
CHN microanalysis Euro A (Elemental Analyzer), (Italy) and H1NMR performed in the center laboratory of 
Esfahan University. Thin layer chromatography (TLC) was run on silica gel GF254 (60), Merck (Germany) to 
check both purity of compounds and their reactions progress. The anticancer study of the synthesized final 
products was done in Iraqi center for cancer and genetic research 
2.3 synthesis  
2.3.1 Synthesis of compound1 (22) 
This is a sulfhydryl-disulfide exchange reaction performed to produce D-Penicillamine linked to 6 -
mercaptopurine 
     An aqueous solution (20 ml) of D-Penicillamine (10 mmol) and potassium hydroxide (20mmo) was adjusted 
to pH 7.5.then added to a suspension of 1A (10 mmol) in potassium chloride solution (2M, 10ml) and the 
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mixture was adjusted to pH 7.5.The mixture was vigorously stirred for 24 hrs. At room temperature. An off 
white precipitate was formed, collected by filtration the precipitated product was formed, collected and washed 
with distilled water, crystallized with hot ethanol, dried in an oven at 70 °C. The percent yield, melting point, 
physical appearance and Rf values are listed in table (A). The FT-IR bands are listed in table (B); CHNS value 
listed in table (C).HNMR data and spectrum are listed in table D 
2.3.2 Synthesis of compound 1A (22) 
Hydrogen peroxide (7.5mmol) was added drop wise to a suspension of 6- mercaptopurine (7.5mmol) in absolute 
ethanol (20 ml) with continuous stirring for 4 hr. at room temperature. A yellow precipitate was formed, 
collected by filtration, washed excessively with distilled water and crystallized from hot ethanol and the product 
was dried in an oven at 70 ºC. The percent yield, melting point, physical appearance and Rf values are listed in 
table (A). The FT-IR is shown in table (B). 
2.3.3 Synthesis of compound 2(15) 
Compound 2A (10mmol) was dissolved in ethanol (50ml) containing 3-4 drops of acetic acid  
 
and refluxed with  
4-Dimethylamino-benzaldehyde (10mmol) for 5 h. Evaporate the solvent under vacuum  , washed the product 
thoroughly with distilled water, dried in an oven at 70 °C ,crystallized from ethanol. This afforded compound 
2A, which was dried in an oven at 70°C.The percent yield, melting point, physical appearance and Rf values are 
listed in table (A). The FT-IR bands are listed in table (B), CHNS value is listed in table (C). HNMR spectrum is 
listed in table D. 
2.3.4 Synthesis of compound 2A (24) 
To 6 Mercaptopurine (0.01 mol) dissolved in ethanol, hydrazine hydrate (0.02mol) was added drop wise 
with stirring and the mixture was then refluxed for (6 h), until disappearance of the H2S gas that was checked by 
lead acetate paper   then the excess solvent was distilled off, the resulting solid was recrystallized from ethanol to 
give the target product. 
The percent yield, melting point, physical appearance and Rf values are listed on table (A). The FT-IR is 
shown in table (B). 
2.3.5 Synthesis of compound 3(25) 
Compound 3 B (0.005 mole) was dissolved in potassium hydroxide solution (0.005 mole) to this solution carbon 
disulfide (0.1 mole) was added with shaking, then refluxed for (40) hrs. (According to lead acetate paper) The 
solvent was evaporated under reduced pressure and the residue then poured into cold water and acidified with 
dilute hydrochloride acid. The precipitate was filtered and recrystallized from ethanol. 
The percent yield, melting point, physical appearance and Rf values are listed on table (A). The FT-IR bands 
are listed in in table (B), CHNS value is listed in in table (C). HNMR spectrum is listed in table D 
  2.3.6 Synthesis of compound 3B (9)  
A mixture of compound 3A (0.08 mole) and hydrazine hydrate 99% (0.4 mole) in ethanol (70 ml) was 
refluxed for 4 hrs. The mixture was concentrated and cooled. The resulted precipitate was filtered and 
recrystallized from Methanol: Water (50:50). The percent yield, melting point, physical appearance and Rf 
values are listed on table (A). The FT-IR is shown in table (B). 
2.3.7 Synthesis of compound 3A (9)  
  6- Mercapto Purine (0.05 mole) was dissolved in potassium hydroxide solution (0.05 mole) to this solution 
ethyl bromo acetate  (0.05 mole) was added drop wise, and refluxed for (9) hrs., then excess solvent was 
evaporated and washed several times with water and 5% sodium bicarbonate solution. Recrystallized from 
ethanol. The percent yield, melting point, physical appearance and Rf values are listed on table (A). The FT-IR 
bands are listed in in table (B). 
     2.3.8 Synthesis of compound 4(15) 
 Compound 3B (10mmol) was dissolved in ethanol (75ml) containing 3-4 drops of acetic acid  
 
and 
refluxed with  1-Naphthylaldehyde (10mmol) for 6 h. Cool the mixture and precipitate was collected by filtration 
, washed thoroughly with distilled water, dried in an oven at 70 °C ,crystallized from n-hexane. This afforded 
compound 4, which was dried in an oven at 70°C. The percent yield, melting point, physical appearance and Rf 
values are listed on table (A). The FT-IR bands are listed in in table (B), CHNS value is listed in in table (C). 
HNMR spectrum is listed in table D  
2.3.9 Synthesis of compound5 (22) 
  To a stirred solution of compound 3B (10 mmol) in (5 ml) N, Dimethyl formamide (DMF). 
A solution of compound 5B (5 mmol) in 8 ml DMF was added to the reaction mixture .The 
mixture was then cooled to (15C), DCC (10 mmol) and HOSU (10 mmol) was added with 
stirring, the stirrer was continued for (120 hrs.) at (0 C) and for (72 hrs.) at ambient 
temperature (20 C). Ethyl acetate (50 ml) was added to the reaction mixture and then filtered 
to get rid of the precipitated N,N-dicyclohexylurea (DCU). The filtrate was evaporated to 
dryness under vacuum, and the residue was re-dissolved in ethyl acetate (50 ml), the excess 
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DCU which was still adhesive on the residue was precipitated out and filtered. The clear 
filtrate was washed twice with (10 ml) HCl (0.1 N) solution, once with (10 ml) D.W, and with 
(10 ml) NaCO3 5% using the separator funnel. The ethyl acetate layer was dried using 
anhydrous magnesium sulfate, and then evaporated to dryness. The percent yield, melting 
point, physical appearance and Rf values are listed on table (A). The FT-IR bands are listed in 
in table (B), CHNS value is listed in in table (C). HNMR spectrum is listed in table D  
2.3.10 Synthesis of compound5B (22)  
Compound 5A (0.05 mole) was dissolved in minimum volume of mixture of dioxane / water 
(5:1) then sodium hydroxide (0.075) was added on period of 30 min., then stirring at room 
temp for 4 hr., equivalent amount of HCl was added, and as crushed ice was added, as 
precipitate appear, filtrated and Recrystallized from methanol. The percent yield, melting 
point, physical appearance and Rf values are listed on table (A). The FT-IR bands are listed in 
table (B). 
2.3.11 Synthesis of compound5A (26) 
  2- Mercapto Benzothiazole (0.05 mole) was dissolved in potassium hydroxide solution (0.05 mole) to this 
solution ethyl bromo acetate  (0.05 mole) was added drop wise and refluxed for (6) hrs., then excess solvent was 
evaporated and washed several times with water and 5% sodium bicarbonate solution Recrystallized from 
ethanol. The percent yield, melting point, physical appearance and Rf values are listed on table (A). The FT-IR 
bands are listed in in table (B) 
2.4 Cytotoxicity against Cancer Cell Lines  
Compounds from 1- 5 were tested for their cytotoxic activity by pilot study, and Compounds 1, reviewed in 
detail and show significance cytotoxic activity, Compounds 1 (20–1 µg/mL) was tested for its cytotoxic activity 
against 3 human cancer cell lines:  HeLa (cervical), AMN3 (adenocarcinoma), RD (Rhabdomyosarcoma), all cell 
lines were maintained in RPMI medium supplemented with 10% fetal bovine serum, compound 1 was dissolved 
with DMF until reaching a concentration of 1 mg/mL. The final concentration of DMF in the culture medium 
was kept constant, below 0.1% (v/v). A compound 1 was incubated with the tested cells as separately for 
24hours. The negative control received the same amount of DMF, The cell viability was determined by reduction 
of the yellow dye 3-(4,5-dimethyl-2-thiazol)-2,5-diphenyl-2H-tetrazolium bromide (MTT) to a blue formazan 
product as described by Mosmann (26), result is listed in table( E) 
3. Results and Discussion 
The present investigation involves the synthesis of new series compounds of D Penicillamine and 6-
mercaptopurine moieties as shown in schemes, the pathway of synthesis of 6- mercaptopurine derivatives 
that have a characteristic imine and Oxadiazole, amide and disulfide moeities. Compound 1 represents 
mutual prodrug as disulfide derivatives. 
Schiff bases were prepared by condensation of 6-mercaptopurine derivatives with suitable aldehyde   using 
acetic acid as catalyst that will increase the nucleophilicty of the amine group, and the reaction was followed 
by IR and showed the appearance of a characteristic absorption bands for (C=N) and (N-H), and 
disappearance of the band for Primary amine group as shown in table (B).  
Compounds were prepared and their chemical structures were proved by spectral and elemental analyses and 
H1NMR. The cytotoxicity activity of these compounds was screened against three cells lines using MTT 
assay method. 
Compound 1 has good, broad spectrum anticancer activity against all tested cell lines.     Compounds 1  
obtained by sulfhydryl-disulfide exchange reaction applied on D-penicillamine  to be reacted with 
compound 1A as an aqueous solution at pH 7.5.This reaction involves a nucleophilic attack (SN2) of the 
thiolate anion of penicillamine  to compound  1A  disulfide as the electrophile. 
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Table (A), the percent yield, melting point, physical appearance and Rf values of synthesized compounds 
Compound no. Color Yield % Melting point Rf value 
1 yellow  powder 40 303-306 0.43 
1A Yellow powder 50 214-217 0.90 
2 yellow crystal 55 255-258 0.89 
2A Golden  powder 65 225-227 0.21 
3 Yellow crystal 40 232-234 0.85 
3B Off white  crystal 60 254-255 0.11 
3A White  powder 70 119-122 0.45 
4 Off white powder 48 285-187 0.95 
5 Yellow  powder 85 202-204 0.93 
5B White crystal 70 148-151 0.70 
5A Yellow crystal 80 74-77 0.90 
 Solvent system:  Methanol chloroform (3:7) 
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Table (B) The FT IR spectral data of synthesized compounds 
 
Characteristic peaks  cm-1 Compound  
No. 
1 * 3481 - 3435 Characteristic stretching vibration of  primary amine group 
* 3412 Characteristic stretching vibration of  secondary  amine group 
* 3091   Characteristic peaks for unsaturated C-H stretching  groups of aromatic ring 
* 2939, 2901 Characteristic peaks for Asymmetric and symmetric saturated C-H methyl  
* 1720 Characteristic peak for carbonyl stretching vibration carboxylic  acid 
* 1656   Characteristic peak stretching vibration for imine groups 
1A *3313 Characteristic one peak for secondary amine group of purine ring. 
*3033  Characteristic peak for unsaturated C-H  groups 
*1681 Characteristic peaks for imine group (purine ring). 
2 *3317 Characteristic peaks for N-H stretching vibration of secondary amines(for NHN=) 
*3197 Characteristic peaks for N-H stretching vibration of secondary amines (Purine). 
*3010 Characteristic peaks for unsaturated C-H. 
*1674 and 1618 Characteristic peak for imine groups (imidazole ring and Schiff ) 
*2960 and 2889 Characteristic peaks for asymmetrical and symmetrical saturated C-H  
2A *3455 and 3398 Characteristic two peaks for primary amine groups. 
*3249 Characteristic one peak for secondary amine groups. 
*1629 Characteristic peak for imine groups 
3 *3429 Characteristic one peak for secondary amine groups. 
*3093 Characteristic peak for unsaturated C-H  methyl   
*2966 and 2812  Characteristic peaks for asymmetrical and symmetrical saturated C-H  
*2565 Characteristic peak for thiol group. 
*1670 and 1618 Characteristic peaks for imine groups 
3B *3321 and 3288 Characteristic two peaks for primary amine groups. 
*3190 Characteristic one peak for secondary amine groups. 
*3099 Characteristic peak for unsaturated C-H  group   
*1672 Characteristic peaks for amide groups 
*1616  Characteristic peaks for imine group 
3A *3288 Characteristic one peak for secondary amine groups. 
*3055 Characteristic peak for unsaturated C-H group. 
*2945 and 2794  Characteristic peaks for asymmetrical and symmetrical saturated C-H  
*1728 Characteristic peaks for ester groups 
*1662 Characteristic peaks for imine group. 
 
4 *3188 Characteristic one peak for secondary amine groups. 
*3076 Characteristic peak for unsaturated C-H group. 
*2962 and 2818  Characteristic peaks for asymmetrical and symmetrical *saturated C-H 
methyl groups 
*1693, 16255 Characteristic peaks for imine groups. (imidazole ring and  Schiff ) 
*1595 and 1568 Characteristic peaks for aromatic ring 
5 *3045 Characteristic peak for unsaturated C-H group. 
*2958 and 2883 Characteristic peaks for asymmetrical and symmetrical saturated C-H  
*1648 Characteristic peaks for amide groups 
*1693, 16255 Characteristic peaks for imine groups. (imidazole ring and Schiff ) 
*1595 and 1568 Characteristic peaks for aromatic ring 
5B *3072 Characteristic peak for unsaturated C-H group. 
*2854 and 2789 Characteristic peaks for asymmetrical and symmetrical saturated C-H  
*1710 Characteristic peaks for carboxylic acid groups 
*1581 and 1560 Characteristic peaks for aromatic ring 
5A *3072 Characteristic peak for unsaturated C-H group. 
*1730 Characteristic peaks for ester groups 
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Table(C), CHNS micro elemental analysis of final compounds 
S% 
calculate / found 
N% 
calculate / found 
H% 
calculate / found 
C% 
calculate / found 
Molecular 
formula 
Cpd   
21.42/21.45 23.39 /23.66 4.38/ 4.36 40.12/ 40.18 C10H13N5O2S2 1 
------- 34.85/ 35.15 5.37 / 5.31 59.77 / 59.13 C14H15N7 2 
24.26/ 24.57 21.20/21.35 3.05/ 3.03 45.44/ 45.18 C10H8N4OS2 3 
8.85/8.71 23.19/23.97 3.89/3.81 59.65/59.02 C18H14N6OS 4 
22.29/22.45 22.72/22.31 3.04/3.01 44.53/45.55 C16H13N7O2S3 5 
 
 
Table E: Growth inhibition (%) of different cancer cell lines after 24 hr incubation with different concentrations 
of compound 1 (µg/ml) 
 
 
 
 
 
 
 
 
 
 
Table (D), HNMR data for synthesized compounds, solvent / (DMSO), BRUKER400 MHZ 
CPD No. δ PPM Groups No. of H Interpretation 
 
 
1 
 
13.7 -NH-Purine 1 Singlet, 1H 
8.2 Purine  ring 1 Singlet, 1H 
8.4 Purine  ring 1 Singlet, 1H 
3.4 NH2-CH- 1 Singlet, 1H 
2.5 NH2- 1 Singlet, 1H 
1.03 CH3- 6 Singlet, 6H 
 
 
 
 
 
2 
2.88 CH3-N 6 Singlet, 6H 
3.4 -NH- 1 Singlet, 1H 
6.74-8.5 
 
• Aromatic 
• Purine 
• benzylidene 
7 Multiplet, 7H(overlap) 
11.9 -NH- Purine 1 Singlet, 1H 
 
 
 
 
3 
14.5 -NH- • Purine 1 Singlet, 1H 
8.7-6.5 
 
• Aromatic 
• Oxadiazole 
4 Multiplet, 4H(overlap) 
4.8 -CH2-S- 2 Singlet, 2H 
3.4 SH- 1 Singlet, 1H 
 
4 
 
 
13.2 -NH- 1 Singlet, 1H 
7.5-8.5 
 
• Aromatic-H 
• Purine 
• benzylidene 
10 Multiplet, 10H(overlap) 
9.11 Purine-C=H- 1 Singlet, 1H 
3.4 -CH2-S- 2 Singlet, 2H 
 
 
 
5 
10.45 -NH- 1 Singlet, 1H 
8.45-8.65 -NH-NH- 2 Doublet , Doublet,2H 
7.3-7.9 • Aromatic-H 
• Purine 
6 Multiplet, 6H(overlap) 
4.4 
3.5 
-CH2-S-Benzothiazole 
-CH2-S Purine 
2 
2 
Singlet, 2H 
Singlet, 2H 
Cell type Growth inhibition (%) 
1 µg 5 µg 10 µg 15 µg 20 µg 
HeLa 46±3.1a 49±4.9a,b 52±4.8b,c 57±3.7c,d 62±4.4d 
RD 44±2.9a 50±4.4a,b 55±5.7b,c 57±5.9c,d 63±4.7d 
AMN3 46±6.9a 59±4.7b 68±5.1c,d 72±8.0d,e 77±5.9e 
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Values are expressed as mean±SD of 10 measurements; values with non-identical superscripts (a,b,c,d,e) within 
the same cell line are significantly different (P<0.05); Hela:, RD, AMN3  
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Figure 1, scheme for synthesis of targets compounds 
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